Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia

Current Hypertension Reports

Volumn 18, Issue 5, 2016, Pages

  LaMarca, Babbette ^a   Amaral, Lorena M ^a   Harmon, Ashlyn C ^a   Cornelius, Denise C ^a   Faulkner, Jessica L ^a   Cunningham, Mark W ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Animal models; Hypertension; Inflammation; Preeclampsia; Pregnancy

Indexed keywords

ANGIOGENIC FACTOR; ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; INTERLEUKIN 17;

CD4+ T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE MODEL; DNA MODIFICATION; GENETIC MODEL; HUMAN; HYPERTENSION; ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PHENOTYPE; PLACENTA DISORDER; PLACENTAL ISCHEMIA; PREECLAMPSIA; REGULATORY T LYMPHOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TH17 CELL; ANIMAL; FEMALE; IMMUNOLOGY; MATERNAL HYPERTENSION; PLACENTA; PREGNANCY; T LYMPHOCYTE; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; ISCHEMIA; PHENOTYPE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; T-LYMPHOCYTES;

EID: 84963756762     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-016-0633-x     Document Type: Review

References (114)

1. Keyes LE et al. Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr Res. 2003;54(1):20–5.
2. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856–69.
3. Thadhani RI, Johnson RJ, Karumanchi SA. Hypertension during pregnancy: a disorder begging for pathophysiological support. Hypertension. 2005;46(6):1250–1.
4. Redman CW. Preeclampsia: a multi-stress disorder. Rev Med Interne. 2011;32 Suppl 1:S41–4.
5. Redman CW, Sargent L. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534–43. Reviews the importance of immune cells and inflammation during normal pregnancy and preeclampsia, respectively
6. Brown CE et al. Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome. Am J Obstet Gynecol. 1990;163(6 Pt 1):1853–61.
7. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol. 2007;2(3):543–9.
8. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002;283(1):R29–45.
9. Lunell NO et al. Uteroplacental blood flow in pregnancy induced hypertension. Scand J Clin Lab Investig Suppl. 1984;169:28–35.
10. Li J, LaMarca B, Reckelhoff JF. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol. 2012;303(1):H1–8.
11. Gilbert JS et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541–50.
12. Odegard RA et al. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950–5.
13. Roberts JM, Escudero C. The placenta in preeclampsia. Hypertens Pregnancy. 2012;2(2):72–83.
14. Ahmed A et al. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review. Placenta. 2000;21 Suppl A:S16–24.
15. Rodesch F et al. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992;80(2):283–5.
16. Zhou Y et al. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest. 1993;91(3):950–60.
17. Zhou Y et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest. 1997;99(9):2139–51.
18. Mabie WC et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol. 1994;170(3):849–56.
19. Jauniaux E, Burton GJ. Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum Dev. 2007;83(11):699–706.
20. Jauniaux E et al. Amniotic gas values and acid–base status during acute maternal hyperoxemia and hypoxemia in the early fetal sheep. Am J Obstet Gynecol. 2000;182(3):661–5.
21. Jauniaux E et al. In-vivo measurement of intrauterine gases and acid–base values early in human pregnancy. Hum Reprod. 1999;14(11):2901–4.
22. Lala PK, Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta. 2003;24(6):575–87.
23. Wells M. The pathology of gestational trophoblastic disease: recent advances. Pathology. 2007;39(1):88–96.
24. King A. Uterine leukocytes and decidualization. Hum Reprod Update. 2000;6(1):28–36.
25. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens. 2004;63(1):1–12.
26. Williams PJ et al. Decidual leucocyte populations in early to late gestation normal human pregnancy. J Reprod Immunol. 2009;82(1):24–31. Describes early immune pregnancy cell populations.
27. Craven CM, Morgan T, Ward K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta. 1998;19(4):241–52.
28. Hanna J et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12(9):1065–74.
29. Somerset DA et al. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004;112(1):38–43.
30. Tilburgs T et al. Evidence for a selective migration of fetus-specific CD4 + CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol. 2008;180(8):5737–45. Describes specific methods for T cells stainings and populations in pregnancy.
31. Veenstra van Nieuwenhoven AL, Heineman MJ, Faas MM, The immunology of successful pregnancy. Hum Reprod Update. 2003;9(4):347–57.
32. Freeman DJ et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension. 2004;44(5):708–14.
33. LaMarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology (Bethesda). 2013;28(4):225–33.
34. Cornelius DC et al. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension. 2013;62(6):1068–73.
35. Irani RA et al. Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension. 2010;55(5):1246–53.
36. Prins JR et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy. 2009;28(3):300–11.
37. Santner-Nanan B et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009;183(11):7023–30. First description of changes in T regs and TH17 during PE.
38. Wallace K et al. CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension. 2011;57(5):949–55.
39. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37(3):240–9.
40. Dhillion P et al. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2012;303(4):R353–8.
41. Granger JP et al. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension. 2001;38(3 Pt 2):718–22.
42. Granger JP et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 2002;9(3):147–60.
43. LaMarca BB et al. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension. 2005;46(1):82–6.
44. LaMarca BD et al. Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med. 2008;5 Suppl A:S133–8.
45. Herse F, LaMarca B. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reprod Immunol. 2013;69(4):413–8.
46. LaMarca B, Wallace K, Granger J. Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. Curr Opin Pharmacol. 2011;11(2):175–9.
47. Parrish MR et al. Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gend Med. 2011;8(3):184–8.
48. Wenzel K et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension. 2011;58(1):77–84.
49. Zhou CC et al. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension. 2008;51(4):1010–9.
50. Podjarny E, Losonczy G, Baylis C. Animal models of preeclampsia. Semin Nephrol. 2004;24(6):596–606.
51. Abitbol MM. A simplified technique to produce toxemia in the pregnant dog. Am J Obstet Gynecol. 1981;139(5):526–34.
52. Woods LL, Brooks VL. Role of the renin-angiotensin system in hypertension during reduced uteroplacental perfusion pressure. Am J Physiol. 1989;257(1 Pt 2):R204–9.
53. Abitbol MM, Driscoll SG, Ober WB. Placental lesions in experimental toxemia in the rabbit. Am J Obstet Gynecol. 1976;125(7):942–8.
54. Abitbol MM et al. Production of experimental toxemia in the pregnant rabbit. Am J Obstet Gynecol. 1976;124(5):460–70.
55. Combs CA et al. Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol. 1993;169(1):215–23.
56. Zhou Y et al. Increased depth of trophoblast invasion after chronic constriction of the lower aorta in rhesus monkeys. Am J Obstet Gynecol. 1993;169(1):224–9.
57. Cavanagh D et al. Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis). Am J Obstet Gynecol. 1985;151(7):987–99.
58. Crews JK et al. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension. 2000;35(1 Pt 2):367–72.
59. Alexander BT et al. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension. 2001;37(4):1191–5.
60. Murphy JG et al. Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure. Am J Physiol Heart Circ Physiol. 2003;284(1):H393–403.
61. Roberts L et al. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension. 2006;47(3):615–8.
62. Alexander BT et al. Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens. 2002;15(2 Pt 1):170–5.
63. Wallukat G et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103(7):945–52. First description of AT1-AA during PE.
64. Sedeek M et al. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens. 2008;21(10):1152–6.
65. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007;50(6):1142–7.
66. Gilbert JS et al. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension. 2009;53(2):399–403.
67. Kupferminc MJ et al. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol. 1994;170(6):1752–7. discussion 1757–9.
68. Gadonski G et al. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension. 2006;48(4):711–6.
69. Heikkinen J et al. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol. 2004;136(2):373–8.
70. Saito S et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63(6):601–10.
71. Sakaguchi S et al. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775–87.
72. Sasaki Y et al. Decidual and peripheral blood CD4 + CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod. 2004;10(5):347–53.
73. Lash GE, Robson SC, Bulmer JN. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta. 2010;31(Suppl):S87–92.
74. Munoz-Suano A, Hamilton AB, Betz AG. Gimme shelter: the immune system during pregnancy. Immunol Rev. 2011;241(1):20–38.
75. Tilburgs T et al. Expression of NK cell receptors on decidual T cells in human pregnancy. J Reprod Immunol. 2009;80(1–2):22–32.
76. Zenclussen AC et al. Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice. Eur J Immunol. 2004;34(2):377–87.
77. Novotny SR et al. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol. 2012;302(10):R1197–201.
78. Novotny S, et al. CD4 T cells play a critical role in mediating hypertension in response to placental ischemia. J Hypertens (Los Angel). 2013;2.
79. Cornelius DC, et al. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension. 2013.
80. Kleinewietfeld M, Hafler DA. Regulatory T cells in autoimmune neuroinflammation. Immunol Rev. 2014;259(1):231–44.
81. Quinn KH et al. The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells. J Reprod Immunol. 2011;91(1–2):76–82.
82. Sasaki Y et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol. 2007;149(1):139–45.
83. von Rango U. Fetal tolerance in human pregnancy--a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett. 2008;115(1):21–32.
84. Zenclussen AC et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4 + CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol. 2005;166(3):811–22.
85. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5(3):266–71.
86. Redman CW et al. Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta. 2012;33(Suppl):S48–54.
87. Chamley LW et al. Trophoblast deportation: just a waste disposal system or antigen sharing? J Reprod Immunol. 2011;88(2):99–105.
88. Lau SY et al. Necrotic trophoblast debris increases blood pressure during pregnancy. J Reprod Immunol. 2013;97(2):175–82.
89. Hubel CA et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension. 2007;49(3):612–7.
90. Brewer J et al. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy. Hypertension. 2013;62(5):886–92.
91. LaMarca B et al. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension. 2009;54(4):905–9.
92. Parrish MR et al. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens. 2010;23(8):911–6.
93. Parrish MR et al. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am J Hypertens. 2011;24(7):835–40.
94. Xia Y, Kellems RE. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond. Circ Res. 2013;113(1):78–87.
95. Quitterer U, Lother H, Abdalla S. AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. Semin Nephrol. 2004;24(2):115–9.
96. AbdAlla S et al. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med. 2001;7(9):1003–9.
97. Nagamatsu T et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology. 2004;145(11):4838–45.
98. Nevo O et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol. 2006;291(4):R1085–93.
99. Makris A et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 2007;71(10):977–84.
100. Maynard SE et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–58.
101. Bridges JP et al. Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens. 2009;22(5):564–8.
102. Murphy SR et al. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension. 2010;55(2):394–8.
103. Li Z et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension. 2007;50(4):686–92.
104. Bergmann A et al. Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med. 2010;14(6B):1857–67.
105. Murphy S et al. Role of endothelin in mediating soluble fms-like tyrosine kinase 1 induced hypertension in pregnant rats. Hypertension. 2010;55:394–8.
106. Gilbert JS et al. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placental ischemia-induced hypertension. Hypertension. 2010;55(2):380–5.
107. Davisson RL et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension. 2002;39(2 Pt 2):337–42.
108. Wallace K et al. Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol. 2012;303(2):R144–9.
109. Woods AK et al. Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice. Hypertension. 2011;57(1):94–102.
110. Shah DM. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Ren Physiol. 2005;288(4):F614–25.
111. Takimoto E et al. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996;274(5289):995–8.
112. Bohlender J, Ganten D, Luft FC. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J Am Soc Nephrol. 2000;11(11):2056–61.
113. Verlohren S et al. Uterine vascular function in a transgenic preeclampsia rat model. Hypertension. 2008;51(2):547–53.
114. Falcao S et al. Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension. Hypertension. 2009;54(6):1401–7.